Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 1 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 02, 2018 Filed Apr 4, 2018 23:14 UTC |
McCourt MarionDirector
|
GrantStock option (right to buy) · Derivative | 11,800 | $0.86 Strike: $1.32 | $10,148.00 |
DisclosureSEC source: 0001209191-18-023924 · doc4.xml · derivative · entry 1 McCourt Marion · CIK 0001663758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,800 Underlying: Common Stock · 11,800 shares Expires 2028-04-01 F1 · price: Stock option received by the Reporting Person pursuant to such Reporting Person's election to receive stock option in lieu of the Reporting Person's annual cash retainers (paid quarterly) under the Compensation Arrangement with Non-Employee Directors policy. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 23:13 UTC |
Macdonald GuyDirector
|
GrantStock option (right to buy) · Derivative | 19,959 | $0.86 Strike: $1.32 | $17,164.74 |
DisclosureSEC source: 0001209191-18-023923 · doc4.xml · derivative · entry 1 Macdonald Guy · CIK 0001296998 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,959 Underlying: Common Stock · 19,959 shares Expires 2028-04-01 F1 · price: Stock option received by the Reporting Person pursuant to such Reporting Person's election to receive stock option in lieu of the Reporting Person's annual cash retainers (paid quarterly) under the Compensation Arrangement with Non-Employee Directors policy. Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 12:10 UTC |
Angulo Gonzalez DavidChief Medical Officer
|
PurchaseCommon Stock | 6,000 | $1.36 | $8,160.00 |
DisclosureSEC source: 0001209191-18-022265 · doc4.xml · nonDerivative · entry 1 Angulo Gonzalez David · CIK 0001644071 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,790 Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:43 UTC |
Angulo Gonzalez DavidChief Medical Officer
|
PurchaseCommon Stock | 7,000 | $1.39 | $9,730.00 |
DisclosureSEC source: 0001209191-18-018877 · doc4.xml · nonDerivative · entry 1 Angulo Gonzalez David · CIK 0001644071 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,790 Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 12:52 UTC |
HASTINGS DAVID CDirector
|
PurchaseCommon Stock Warrant (right to buy) · Derivative | 5,325 | Not disclosed Strike: $2.00 | Not disclosed |
DisclosureSEC source: 0001209191-18-018711 · doc4.xml · derivative · entry 3 HASTINGS DAVID C · CIK 0001237401 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,325 Underlying: Common Stock · 5,325 shares Expires 2023-03-08 F1 · price: Reflects the purchase on March 8, 2018, of 11,834 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant). Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 12:52 UTC |
HASTINGS DAVID CDirector
|
PurchaseCommon Stock Warrant (right to buy) · Derivative | 8,875 | Not disclosed Strike: $1.85 | Not disclosed |
DisclosureSEC source: 0001209191-18-018711 · doc4.xml · derivative · entry 2 HASTINGS DAVID C · CIK 0001237401 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,875 Underlying: Common Stock · 8,875 shares Expires 2019-03-14 F1 · price: Reflects the purchase on March 8, 2018, of 11,834 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant). Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 12:52 UTC |
HASTINGS DAVID CDirector
|
PurchaseCommon Stock | 11,834 | $1.69 | $19,999.46 |
DisclosureSEC source: 0001209191-18-018711 · doc4.xml · nonDerivative · entry 1 HASTINGS DAVID C · CIK 0001237401 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,834 F1 · price: Reflects the purchase on March 8, 2018, of 11,834 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant). Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 12:51 UTC |
Sukenick ScottGeneral Counsel
|
PurchaseCommon Stock Warrant (right to buy) · Derivative | 1,331 | Not disclosed Strike: $2.00 | Not disclosed |
DisclosureSEC source: 0001209191-18-018709 · doc4.xml · derivative · entry 3 Sukenick Scott · CIK 0001722886 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,331 Underlying: Common Stock · 1,331 shares Expires 2023-03-08 F1 · price: Reflects the purchase on March 8, 2018, of 2,959 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant). Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 12:51 UTC |
Sukenick ScottGeneral Counsel
|
PurchaseCommon Stock Warrant (right to buy) · Derivative | 2,219 | Not disclosed Strike: $1.85 | Not disclosed |
DisclosureSEC source: 0001209191-18-018709 · doc4.xml · derivative · entry 2 Sukenick Scott · CIK 0001722886 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,219 Underlying: Common Stock · 2,219 shares Expires 2019-03-14 F1 · price: Reflects the purchase on March 8, 2018, of 2,959 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant). Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 12:51 UTC |
Sukenick ScottGeneral Counsel
|
PurchaseCommon Stock | 2,959 | $1.69 | $5,000.71 |
DisclosureSEC source: 0001209191-18-018709 · doc4.xml · nonDerivative · entry 1 Sukenick Scott · CIK 0001722886 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,959 F1 · price: Reflects the purchase on March 8, 2018, of 2,959 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant). Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 12:50 UTC |
Taglietti MarcoDirector · Chief Executive Officer
|
PurchaseCommon Stock Warrant (right to buy) · Derivative | 45,000 | Not disclosed Strike: $2.00 | Not disclosed |
DisclosureSEC source: 0001209191-18-018708 · doc4.xml · derivative · entry 3 Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2023-03-08 F1 · price: Reflects the purchase on March 8, 2018, of 100,000 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant). Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 12:50 UTC |
Taglietti MarcoDirector · Chief Executive Officer
|
PurchaseCommon Stock Warrant (right to buy) · Derivative | 75,000 | Not disclosed Strike: $1.85 | Not disclosed |
DisclosureSEC source: 0001209191-18-018708 · doc4.xml · derivative · entry 2 Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2019-03-14 F1 · price: Reflects the purchase on March 8, 2018, of 100,000 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant). Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 12:50 UTC |
Taglietti MarcoDirector · Chief Executive Officer
|
PurchaseCommon Stock | 100,000 | $1.69 | $169,000.00 |
DisclosureSEC source: 0001209191-18-018708 · doc4.xml · nonDerivative · entry 1 Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 404,000 F1 · price: Reflects the purchase on March 8, 2018, of 100,000 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant). Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 12:49 UTC |
Francois EricChief Financial Officer
|
PurchaseCommon Stock Warrant (right to buy) · Derivative | 2,662 | Not disclosed Strike: $2.00 | Not disclosed |
DisclosureSEC source: 0001209191-18-018707 · doc4.xml · derivative · entry 3 Francois Eric · CIK 0001656125 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,662 Underlying: Common Stock · 2,662 shares Expires 2023-03-08 F1 · price: Reflects the purchase on March 8, 2018, of 5,917 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant). Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 12:49 UTC |
Francois EricChief Financial Officer
|
PurchaseCommon Stock Warrant (right to buy) · Derivative | 4,437 | Not disclosed Strike: $1.85 | Not disclosed |
DisclosureSEC source: 0001209191-18-018707 · doc4.xml · derivative · entry 2 Francois Eric · CIK 0001656125 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,437 Underlying: Common Stock · 4,437 shares Expires 2019-03-14 F1 · price: Reflects the purchase on March 8, 2018, of 5,917 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant). Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 12:49 UTC |
Francois EricChief Financial Officer
|
PurchaseCommon Stock | 5,917 | $1.69 | $9,999.73 |
DisclosureSEC source: 0001209191-18-018707 · doc4.xml · nonDerivative · entry 1 Francois Eric · CIK 0001656125 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,917 F1 · price: Reflects the purchase on March 8, 2018, of 5,917 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant). Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 12:48 UTC |
Angulo Gonzalez DavidChief Medical Officer
|
PurchaseCommon Stock Warrant (right to buy) · Derivative | 6,655 | Not disclosed Strike: $2.00 | Not disclosed |
DisclosureSEC source: 0001209191-18-018705 · doc4.xml · derivative · entry 3 Angulo Gonzalez David · CIK 0001644071 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,655 Underlying: Common Stock · 6,655 shares Expires 2023-03-08 F1 · price: Reflects the purchase on March 8, 2018, of 14,790 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant). Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 12:48 UTC |
Angulo Gonzalez DavidChief Medical Officer
|
PurchaseCommon Stock Warrant (right to buy) · Derivative | 11,092 | Not disclosed Strike: $1.85 | Not disclosed |
DisclosureSEC source: 0001209191-18-018705 · doc4.xml · derivative · entry 2 Angulo Gonzalez David · CIK 0001644071 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,092 Underlying: Common Stock · 11,092 shares Expires 2019-03-14 F1 · price: Reflects the purchase on March 8, 2018, of 14,790 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant). Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 12:48 UTC |
Angulo Gonzalez DavidChief Medical Officer
|
PurchaseCommon Stock | 14,790 | $1.69 | $24,995.10 |
DisclosureSEC source: 0001209191-18-018705 · doc4.xml · nonDerivative · entry 1 Angulo Gonzalez David · CIK 0001644071 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,790 F1 · price: Reflects the purchase on March 8, 2018, of 14,790 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant). Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 22:06 UTC |
Angulo Gonzalez DavidChief Medical Officer
|
GrantStock option (right to buy) · Derivative | 200,000 | $0.00 Strike: $1.69 | $0.00 |
DisclosureSEC source: 0001209191-18-009636 · doc4.xml · derivative · entry 1 Angulo Gonzalez David · CIK 0001644071 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2028-02-08 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 22:05 UTC |
Francois EricChief Financial Officer
|
GrantStock option (right to buy) · Derivative | 150,000 | $0.00 Strike: $1.69 | $0.00 |
DisclosureSEC source: 0001209191-18-009633 · doc4.xml · derivative · entry 1 Francois Eric · CIK 0001656125 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2028-02-08 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 22:04 UTC |
Taglietti MarcoDirector · Chief Executive Officer
|
GrantStock option (right to buy) · Derivative | 375,000 | $0.00 Strike: $1.69 | $0.00 |
DisclosureSEC source: 0001209191-18-009630 · doc4.xml · derivative · entry 1 Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,000 Underlying: Common Stock · 375,000 shares Expires 2028-02-08 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 22:03 UTC |
Sukenick ScottGeneral Counsel
|
GrantStock option (right to buy) · Derivative | 15,000 | $0.00 Strike: $1.69 | $0.00 |
DisclosureSEC source: 0001209191-18-009627 · doc4.xml · derivative · entry 1 Sukenick Scott · CIK 0001722886 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2028-02-08 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 17:31 UTC |
McCourt MarionDirector
|
GrantStock Option (right to buy) · Derivative | 6,831 | $1.48 Strike: $2.28 | $10,109.88 |
DisclosureSEC source: 0001209191-18-001749 · doc4.xml · derivative · entry 1 McCourt Marion · CIK 0001663758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,831 Underlying: Common Stock · 6,831 shares Expires 2028-01-01 F1 · price: This option was issued to the Reporting Person pursuant to the Issuer's Compensation Arrangement with Non-Employee Directors policy in lieu of the Reporting Person's annual cash retainers (paid quarterly) under such policy. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 17:25 UTC |
Macdonald GuyDirector
|
GrantStock Option (right to buy) · Derivative | 11,555 | $1.48 Strike: $2.28 | $17,101.40 |
DisclosureSEC source: 0001209191-18-001742 · doc4.xml · derivative · entry 1 Macdonald Guy · CIK 0001296998 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,555 Underlying: Common Stock · 11,555 shares Expires 2028-01-01 F1 · price: This option was issued to the Reporting Person pursuant to the Issuer's Compensation Arrangement with Non-Employee Directors policy in lieu of the Reporting Person's annual cash retainers (paid quarterly) under such policy. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 17:30 UTC |
McCourt MarionDirector
|
GrantStock Option (right to buy) · Derivative | 19,989 | $0.00 Strike: $2.28 | $0.00 |
DisclosureSEC source: 0001209191-18-001745 · doc4.xml · derivative · entry 1 McCourt Marion · CIK 0001663758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,989 Underlying: Common Stock · 19,989 shares Expires 2028-01-01 F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant; provided, that the non-employee director is providing continuous services on the applicable vesting date. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 17:26 UTC |
Machado PatrickDirector
|
GrantStock Option (right to buy) · Derivative | 19,989 | $0.00 Strike: $2.28 | $0.00 |
DisclosureSEC source: 0001209191-18-001743 · doc4.xml · derivative · entry 1 Machado Patrick · CIK 0001311210 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,989 Underlying: Common Stock · 19,989 shares Expires 2028-01-01 F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant; provided, that the non-employee director is providing continuous services on the applicable vesting date. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 17:22 UTC |
HASTINGS DAVID CDirector
|
GrantStock Option (right to buy) · Derivative | 19,989 | $0.00 Strike: $2.28 | $0.00 |
DisclosureSEC source: 0001209191-18-001740 · doc4.xml · derivative · entry 1 HASTINGS DAVID C · CIK 0001237401 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,989 Underlying: Common Stock · 19,989 shares Expires 2028-01-01 F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant; provided, that the non-employee director is providing continuous services on the applicable vesting date. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 17:23 UTC |
Macdonald GuyDirector
|
GrantStock Option (right to buy) · Derivative | 19,989 | $0.00 Strike: $2.28 | $0.00 |
DisclosureSEC source: 0001209191-18-001741 · doc4.xml · derivative · entry 1 Macdonald Guy · CIK 0001296998 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,989 Underlying: Common Stock · 19,989 shares Expires 2028-01-01 F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant; provided, that the non-employee director is providing continuous services on the applicable vesting date. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 17:20 UTC |
GILMAN STEVEN CDirector
|
GrantStock Option (right to buy) · Derivative | 19,989 | $0.00 Strike: $2.28 | $0.00 |
DisclosureSEC source: 0001209191-18-001738 · doc4.xml · derivative · entry 1 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,989 Underlying: Common Stock · 19,989 shares Expires 2028-01-01 F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant; provided, that the non-employee director is providing continuous services on the applicable vesting date. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 17:21 UTC |
HANHAM ANNDirector
|
GrantStock Option (right to buy) · Derivative | 19,989 | $0.00 Strike: $2.28 | $0.00 |
DisclosureSEC source: 0001209191-18-001739 · doc4.xml · derivative · entry 1 HANHAM ANN · CIK 0001286338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,989 Underlying: Common Stock · 19,989 shares Expires 2028-01-01 F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant; provided, that the non-employee director is providing continuous services on the applicable vesting date. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:13 UTC |
Sukenick ScottGeneral Counsel
|
GrantStock Option (right to buy) · Derivative | 160,000 | $0.00 Strike: $1.75 | $0.00 |
DisclosureSEC source: 0001209191-17-061447 · doc4.xml · derivative · entry 1 Sukenick Scott · CIK 0001722886 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 160,000 shares Expires 2027-11-14 F1 · derivative.exercise_date: 25% of the shares subject to this option vests on the one-year anniversary of the grant date with the remainder vesting in equal monthly installments for thirty-six (36) months thereafter, provided the executive continues to provide continuous services to us. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:29 UTC |
Macdonald GuyDirector
|
GrantStock Option (right to buy) · Derivative | 10,709 | $0.00 Strike: $2.46 | $0.00 |
DisclosureSEC source: 0001178253-17-000022 · wf-form4_150714892902213.xml · derivative · entry 1 Macdonald Guy · CIK 0001296998 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,709 Underlying: Common Stock · 10,709 shares Expires 2027-10-02 Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:29 UTC |
McCourt MarionDirector
|
GrantStock Option (right to buy) · Derivative | 6,332 | $0.00 Strike: $2.46 | $0.00 |
DisclosureSEC source: 0001178253-17-000023 · wf-form4_150714894713361.xml · derivative · entry 1 McCourt Marion · CIK 0001663758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,332 Underlying: Common Stock · 6,332 shares Expires 2027-10-02 Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:28 UTC |
GILMAN STEVEN CDirector
|
GrantStock Option (right to buy) · Derivative | 1,807 | $0.00 Strike: $2.46 | $0.00 |
DisclosureSEC source: 0001178253-17-000021 · wf-form4_150714891078360.xml · derivative · entry 1 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,807 Underlying: Common Stock · 1,807 shares Expires 2027-10-02 Read SEC document |
| September 22, 2017 Filed Sep 25, 2017 20:34 UTC |
Taglietti MarcoDirector · Chief Executive Officer
|
PurchaseCommon Stock | 10,000 | $2.23 | $22,300.00 |
DisclosureSEC source: 0001178253-17-000020 · wf-form4_150637165803274.xml · nonDerivative · entry 1 Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,000 Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 13:28 UTC |
Taglietti MarcoDirector · Chief Executive Officer
|
PurchaseCommon Stock | 4,993 | $1.85 | $9,237.05 |
DisclosureSEC source: 0001178253-17-000019 · wf-form4_150358132152635.xml · nonDerivative · entry 2 Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,000 Read SEC document |
| August 22, 2017 Filed Aug 24, 2017 13:28 UTC |
Taglietti MarcoDirector · Chief Executive Officer
|
PurchaseCommon Stock | 7 | $1.61 | $11.27 |
DisclosureSEC source: 0001178253-17-000019 · wf-form4_150358132152635.xml · nonDerivative · entry 1 Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,007 Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 13:32 UTC |
Taglietti MarcoDirector · Chief Executive Officer
|
PurchaseCommon Stock | 10,000 | $1.61 | $16,100.00 |
DisclosureSEC source: 0001178253-17-000018 · wf-form4_150297672592049.xml · nonDerivative · entry 1 Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,000 Read SEC document |
| August 11, 2017 Filed Aug 14, 2017 20:29 UTC |
Angulo Gonzalez DavidChief Medical Officer
|
PurchaseCommon Stock | 10,000 | $1.55 | $15,500.00 |
DisclosureSEC source: 0001178253-17-000017 · wf-form4_150274201826748.xml · nonDerivative · entry 1 Angulo Gonzalez David · CIK 0001644071 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,000 Read SEC document |
| July 03, 2017 Filed Jul 5, 2017 19:55 UTC |
McCourt MarionDirector
|
GrantStock Option (right to buy) · Derivative | 8,511 | $0.00 Strike: $1.83 | $0.00 |
DisclosureSEC source: 0001178253-17-000014 · wf-form4_149928452238964.xml · derivative · entry 1 McCourt Marion · CIK 0001663758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,511 Underlying: Common Stock · 8,511 shares Expires 2027-07-03 Read SEC document |
| July 03, 2017 Filed Jul 5, 2017 19:55 UTC |
Macdonald GuyDirector
|
GrantStock Option (right to buy) · Derivative | 14,396 | $0.00 Strike: $1.83 | $0.00 |
DisclosureSEC source: 0001178253-17-000013 · wf-form4_149928450673911.xml · derivative · entry 1 Macdonald Guy · CIK 0001296998 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,396 Underlying: Common Stock · 14,396 shares Expires 2027-07-03 Read SEC document |
| July 03, 2017 Filed Jul 5, 2017 19:54 UTC |
GILMAN STEVEN CDirector
|
GrantStock Option (right to buy) · Derivative | 2,430 | $0.00 Strike: $1.83 | $0.00 |
DisclosureSEC source: 0001178253-17-000012 · wf-form4_149928448463882.xml · derivative · entry 1 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,430 Underlying: Common Stock · 2,430 shares Expires 2027-07-03 Read SEC document |
| June 21, 2017 Filed Jun 22, 2017 12:58 UTC |
HASTINGS DAVID CDirector
|
PurchaseCommon Stock | 20,000 | $1.75 | $35,000.00 |
DisclosureSEC source: 0001178253-17-000011 · wf-form4_149813632239136.xml · nonDerivative · entry 1 HASTINGS DAVID C · CIK 0001237401 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Read SEC document |
| May 12, 2017 Filed May 15, 2017 12:17 UTC |
Taglietti MarcoDirector · Chief Executive Officer
|
PurchaseCommon Stock | 25,000 | $1.69 | $42,250.00 |
DisclosureSEC source: 0001178253-17-000009 · wf-form4_149485065910342.xml · nonDerivative · entry 1 Taglietti Marco · CIK 0001408870 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,000 Read SEC document |
| May 12, 2017 Filed May 15, 2017 12:17 UTC |
Angulo Gonzalez DavidChief Medical Officer
|
PurchaseCommon Stock | 15,000 | $1.70 | $25,500.00 |
DisclosureSEC source: 0001178253-17-000008 · wf-form4_149485063942281.xml · nonDerivative · entry 1 Angulo Gonzalez David · CIK 0001644071 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,000 Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 18:40 UTC |
GILMAN STEVEN CDirector
|
GrantStock Option (right to buy) · Derivative | 1,678 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001178253-17-000005 · wf-form4_149133119945040.xml · derivative · entry 1 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,678 Underlying: Common Stock · 1,678 shares Expires 2027-04-03 Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 18:39 UTC |
McCourt MarionDirector
|
GrantStock Option (right to buy) · Derivative | 5,878 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001178253-17-000004 · wf-form4_149133118107433.xml · derivative · entry 1 McCourt Marion · CIK 0001663758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,878 Underlying: Common Stock · 5,878 shares Expires 2027-04-03 Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 18:39 UTC |
Macdonald GuyDirector
|
GrantStock Option (right to buy) · Derivative | 9,941 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001178253-17-000003 · wf-form4_149133115837413.xml · derivative · entry 1 Macdonald Guy · CIK 0001296998 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,941 Underlying: Common Stock · 9,941 shares Expires 2027-04-03 Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 19:23 UTC |
Francois EricChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001628280-17-000756 · wf-form4_148606341188146.xml · derivative · entry 1 Francois Eric · CIK 0001656125 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-01-31 F1 · derivative.exercise_date: 2.08% of the shares subject to the option vest monthly for 48 months as measured from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.